Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia With a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-1023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the Thioredoxin System as a Novel Strategy Against B Cell Acute Lymphoblastic Leukemia

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

PAX5-KIAA1549L: A Novel Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2015English

The Many Faces of IKZF1 in B-Cell Precursor Acute Lymphoblastic Leukemia

Haematologica
Hematology
2018English

Neonatal Inflammatory Markers Are Associated With Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Cancer Research
Cancer ResearchOncology
2018English

Novel Immunotherapies for Adult Patients With B-Lineage Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Inhibition of Notch Signaling Enhances Chemosensitivity in B Cell Precursor Acute Lymphoblastic Leukemia.

Cancer Research
Cancer ResearchOncology
2018English

B-Cell Precursor Acute Lymphoblastic Leukemia and Stromal Cells Communicate Through Galectin-3

Oncotarget
Oncology
2015English

Proteomic Tools and New Insights for the Study of B-Cell Precursor Acute Lymphoblastic Leukemia

Hematology
Hematology
2019English

Efficacy of an Anti-Cd22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B-Cell Acute Lymphoblastic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy